accepted is that one has not been found that meets all of these criteria. However, if we identifSrwhich of the characteristics are the most important, we should then, making minor compromises, be able to select the best acceptor. Some of the compounds that have been evaluated by investigators include the following: Tris, AMP, 2-amino-2-methyl-1,3-propanediol, diethanolamine (DEA), 2-(ethylamino)-ethanol (EAE), ethanolamine, and N-inethyl-D-glucamine. Elsewhere my coworkers and I published a thorough kinetic assessment of these compounds as phosphoacceptorsfor the human ALP isoenzymes from placenta, adult intestine, and liver, and made someconclusionsabout the preferred acceptor for routine assay of ALP in sera (3). Under saturating conditions, DEA was the best acceptorof phosphate. However, the Km of this compound was 9.8 times higher for the placental isoenzyme and 2.5 times higher for the liver enzyme than the Km for EAE. Therefore, to saturate the placental enzyme would require a DEA concentration of at least five times its Km, or about 25 mol/L. Stated another way, the placental isoenzyme would exhibit only 11% of its V in DEA (1 mol/L) but 66% of its V,,, in an equal concentration of EAE. The equivalent value in N-methyl-D-glucamine is 53%, but this compound did not increase V,,, to the extent that DEA and EAE did. Thus, the rate of formation of p-nitrophenol from p-nitrophenyl phosphate in the presenceof ALP is greatest in EAE. Another consideration as part of a thorough evaluation, although not addressed here, is how these phosphoacceptors affect the Km for p-nitrophenyl phosphate.
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Considering the phosphoacceptors as activators allows us to evaluate their activation effects on the phosphohydrolytic activity of ALP and the effects of inhibitors as impurities in these chemicals in the presence of the enhanced phosphotransferase activity. This measure of efficiency of the phosphoacceptors is most important in routine clinical assays and is reflected by a ratio of Va/K (U/mol). This ratio (averaged for the isoenzymes from placenta, intestine, and liver) was 19 for EAE, 8.6 for DEA, and only 5.3 for N-methyl-D-glucamine
(3).
Clearly, under the conditions we used, EAE is the compound of choice. Of great importance in an evaluation of this type is the purity of the phosphoaccepthrs. We used in each case what we believed to be the highest quality available, including "Gold Label" EAE from Aldrich Chemical Co.
I urge investigators who are evaluating compounds to serve as phosphoacceptors and buffers in ALP assays to keep these basic kinetic considerations in mind. 
Dlgoxln-iIke ImmunoreactivIty in Saliva and Plasma of Pregnant Women
To the Editor: (3,4) , sofar no study on EDLI in saliva has been published. In view of our previous finding (7) of significant correlation between salivary and serum concentrations of digoxin, we undertook the present study to examine the possibility of finding EDLI in saliva. Furthermore we found a significant correlation between salivary magnesium and serum digoxin concentrations in patients treated with digoxin (9).
We measured EDLI expressed as nanograins of digoxin equivalent per liter (ng/L) in stimulated and unstimulated saliva and plasma of 20 term pregnant women, known to have increased EDLI in plasma (5) and in 10 healthy nonpregnant women. All the patients and controls were normotensive, and none of them received digoxin, contraceptives, or other medication known to cross-react with the digoxin radioimmunoassay.
EDLI was measured, in duplicate on the same day, by radioimmunoassay (RIANEN; New England Nuclear, Billerica, MA) as described by us elsewhere (3), with an intra-assay CV of 6.8%. Saliva and blood specimens were collected concurrently into chilled heparinized glass tubes. Blood was centrifuged for 10 mm (1000 x g) and plasma was stored at -30 #{176}C until assay. For the collection of unstimuhated saliva, subjects were instructed to let saliva accumulate in their mouth, then expectorate it into a test tube for a 10-mm period (9). For stimulated saliva, subjects' tongues were swabbed every 30 s with a cotton applicator containing citric acid solution before expectorationinto the test tube for a lO-min period (8). All saliva sampleswere centrifuged for 20 mm (1000 x g) and the supernates stored at -30 #{176}C until assay, as described for plasma. We also stored 1 mL of unstimulated saliva at 4#{176}C after centrif ugation until assayed for magnesium. The lower limit of sensitivity for EDLI was 50 ng/L (3). For statistical analysis, all EDLI values below the detection limit were considered as having concentrations at the lower limit of detection.Saliva was assayedfor magnesium by atomic absorption spectrophotometry (9). 
